Anson Funds Management’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-105,685
| Closed | -$45.4K | – | 112 |
|
|
2025
Q1 | $45.4K | Buy |
105,685
+101,048
| +2,179% | +$43.4K | 0.01% | 98 |
|
|
2024
Q4 | $89.9K | Hold |
4,637
| – | – | 0.01% | 116 |
|
|
2024
Q3 | $128K | Buy |
+4,637
| New | +$128K | 0.01% | 120 |
|
|
2018
Q1 | – | Sell |
-2
| Closed | -$446K | – | 37 |
|
|
2017
Q4 | $446K | Buy |
+2
| New | +$446K | 0.3% | 26 |
|
|
2017
Q3 | – | Sell |
-4
| Closed | -$1.39M | – | 46 |
|
|
2017
Q2 | $1.39M | Buy |
+4
| New | +$1.39M | 0.44% | 25 |
|
|
2016
Q2 | – | Sell |
-2
| Closed | -$1.37M | – | 52 |
|
|
2016
Q1 | $1.37M | Buy |
+2
| New | +$1.37M | 0.2% | 23 |
|